Assertio Therapeutics (ASRT) PT Lowered to $4 at Lake Street Capital Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts ASRT Hot Sheet
Price: $23.50 --0%
Rating Summary:
9 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Rating Summary:
9 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Join SI Premium – FREE
Lake Street Capital Markets analyst Thomas Flaten lowered the price target on Assertio Therapeutics (NASDAQ: ASRT) to $4.00 (from $7.00) while maintaining a Buy rating.
You May Also Be Interested In
- North American Construction Group (NOA:CN) (NOA) PT Lowered to Cdn$20 at BMO Capital
- Revolution (RVMD) PT Raised to $272 at Morgan Stanley
- SPS Commerce (SPSC) PT Raised to $76 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
